Insider Transactions in Q4 2021 at Eq Rx, Inc. (EQRX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2021
|
Paul L Berns Director |
BUY
Grant, award, or other acquisition
|
Direct |
627,000
+50.0%
|
-
|
|
Dec 17
2021
|
Alexis Borisy Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
18,810,000
+50.0%
|
-
|
|
Dec 17
2021
|
Amy Abernethy Director |
BUY
Other acquisition or disposition
|
Direct |
200,000
+50.0%
|
-
|
|
Dec 17
2021
|
Amy Abernethy Director |
SELL
Other acquisition or disposition
|
Direct |
200,000
-100.0%
|
-
|
|
Dec 17
2021
|
Amy Abernethy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
200,000
+50.0%
|
-
|
|
Dec 17
2021
|
Sandra Horning Director |
BUY
Grant, award, or other acquisition
|
Direct |
470,250
+50.0%
|
-
|
|
Dec 17
2021
|
Melanie Nallicheri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,851,147
+50.0%
|
-
|
|
Dec 17
2021
|
Melanie Nallicheri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,679,247
+50.0%
|
-
|
|
Dec 17
2021
|
Eric Hedrick Chief Physician Executive |
BUY
Grant, award, or other acquisition
|
Direct |
627,000
+50.0%
|
-
|
|
Dec 17
2021
|
Eli Casdin > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Indirect |
39,527,671
+26.91%
|
$197,638,355
$5.0 P/Share
|
|
Dec 17
2021
|
Eli Casdin > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
8,659,372
+50.0%
|
-
|
|
Dec 17
2021
|
Jorge Conde Director |
BUY
Grant, award, or other acquisition
|
Indirect |
53,064,157
+50.0%
|
$530,641,570
$10.0 P/Share
|
|
Dec 17
2021
|
Jami Rubin Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,194,500
+50.0%
|
-
|